Navigation Links
Vioxx in Medical News

The Lanier Law Firm Will Appeal Court Reversal of Jury Award to Widow in Nation's 1st Vioxx Trial

HOUSTON, May 29 /PRNewswire/ -- The Lanier Law Firm is announcing its plans to appeal a decision issued today by the 14th Court of Appeals in Brazoria County in favor of Whitehouse Station, N.J.-based Merck & Co. (NYSE: MRK ). In the ruling, the court overturned a jury's determination that th...

Key Vioxx Research Was Written by Merck, Documents Allege

Reports say academics were paid to lend their names to ghost-written studies that exaggerated painkiller's safety TUESDAY, April 15 (HealthDay News) -- Industry documents reveal that pharmaceutical giant Merck & Co. paid academics to put their names on Vioxx research published in t...

The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.

Mark Lanier, winner of nation's first Vioxx trial, hails settlement as 'the right thing to do' HOUSTON, Nov. 9 /PRNewswire/ -- Attorneys from The Lanier Law Firm are announcing a nationwide settlement agreement with pharmaceutical giant Merck & Co. Inc. (NYSE: MRK ) th...

Study Points to Cause of Vioxx Heart Risk

The drug ups levels of a protein linked to clotting, researchers say MONDAY, Aug. 27 (HealthDay News) -- Researchers believe they've zeroed in on what caused Vioxx to boost users' heart risks. The popular pain reliever was taken off the market in 2004 because it was linked to a high...

New study may explain Vioxx side-effects

Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects. The ne...

Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx

HARRISBURG, Pa., May 20 /PRNewswire-USNewswire/ -- Pennsylvania, along with 28 other states and the District of Columbia, reached a $58 million settlement, the largest ever for a multi-state consumer protection drug case, with Merck over allegations of deceptive advertising related to the drug...

Arcoxia Slammed –Nothing Better Than Vioxx Says FD

Drug giant Merck is in trouble again. The Federal Drug Administration of U.S (FDA) has rejected its proposed successor(Arcoxia) to the drug Vioxx, //that was pulled out of the market due to safety reasons. The arthritis drug Arcoxia which belongs to the same class of drugs as Vioxx ,was voted...

Doctor Grilled In Court For False Report About Vioxx Health Risk

The doctor, who had dismissed increased risk of heart attack associated with Vioxx, has been accused by lawyers who argue that his views are 'out of the mainstream' as it is based on biased research //, funded by the drug company, Merck and Co. Thomas Cona and John Mcdarby have sued the pharm...

Could Long Tern Vioxx Users Suffer From Heart Attacks?

Dr. Barry Rayburn, a cardiologist from the University of Alabama, Birmingham, told a jury at the latest Vioxx product liability trial that the drug showed no significant difference in the rate of heart attacks //among its users and those taking similar drugs or placebos. The drug Vioxx is produced ...

Judgment In Favor Of Merck For Vioxx Drug

Atlantic City jury has given a judgment in favor of Merck the manufacturers of the controversy drug Vioxx which caused heart attacks in patients who took the drug. The judgment had said that the Merck will not be held liable //for the 2001 heart attack suffered by a man taking the painkiller, but ...

Merck to pay $ 253.5 million to Vioxx victim family

On Friday, a Texas jury found Merck liable for the death of Robert C. Ernst, who died in May 2001 after taking Vioxx, a pain killer made by the company. After two days of deliberations, the jury said that Carol Ernst, Mr. Ernst’s widow, // should be awarded $ 253.5 million. Over 5 years, abou...

A Stroke of Bad Luck for Vioxx

The anti-inflammatory drug Vioxx has been in the news for the wrong reasons and now scientists seem to have more clarity regarding Vioxx and the causative agent of the side-//effects. The answer hovers around the vital property of the drug - the blood clotting mechanism, British scientists reveal. ...

Merck in the Dock Due To Vioxx

The Vioxx case takes a bad turn when the Texas jury awarded $32 million for the family of a 71-year-old man who had died after consuming the painkiller Vioxx. // But this will be greatly reduced by state law. The legal experts say that the verdict is a weak case against Vioxx maker Merck & Co. Inc....

Master Stem Cell for Human Heart Identified

...t that many widely used and valuable drugs, such as Herceptin (for cancer) and Avandia (for diabetes), have heart-related side effects. The painkiller vioxx was withdrawn from the market after widely publicized side effects were noted. The breakthrough research "offers more understanding of how to model...

FDA to Study Ways to Be More Open With Public

... the FDA's credibility has been damaged over a variety of perceived missteps. Problems have included the belated decision to remove the painkiller vioxx from the market long after clinical data showed it increased the risk of heart attack. Another series of problems arose recently over the FDA's oversi...

U.S. Public Lacks Confidence in FDA: Poll

... have gone up and down," said Humphrey Taylor, chairman of The Harris Poll. "I think what happens is that, as stories break about drug problems -- and vioxx comes to mind -- those numbers go up. We seem to have recovered from the low figures of last year," he added. However, on the list of things people...

Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects

...(NSAIDs). This class of drugs has also been shown to reduce colorectal polyps, a precursor to colorectal cancer. But two blockbuster COX-2 inhibitors, vioxx (rofecoxib) and Bextra (valdecoxib), were pulled off the market after reports that they elevated the risk of heart attack, stroke and death in users. ...

Licorice compound offers new cancer prevention strategy

...the prostaglandins. Inhibiting this enzyme with non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or with selective COX-2 inhibitors like vioxx or Celebrex reduces the number and size of colon polyps in mice and in patients with an inherited predisposition to colon cancer. However, both types...

CMEFirst Presents State-of-the-Art Arthritis CME Symposium

...ception of many patients who still recall the media blitz of reports surrounding the cardiovascular complications associated with the long term use of vioxx and other "COX-2" analgesics. This is remarkable since simple analgesics such as acetaminophen (Tylenol(R)) and the NSAIDs are the single most commonl...

Researchers detail how aging undermines bone healing

...humans that is responsible for producing the COX-2 enzyme and revealed the enzyme's role in causing inflammation, the reason drugs like the painkiller vioxx were developed to shut down its action. Then about seven years ago another research team here determined that COX-2 also plays an essential role in bo...

Prostaglandin receptor key to atherosclerosis development

...e, causing heart attacks and strokes. If the latter is true, Linton said, the current studies could offer a mechanistic explanation for how the drug vioxx increased heart attacks in patients. Vioxx, a selective inhibitor of the enzyme cyclooxygenase-2 (COX-2), was withdrawn from the market because of con...

Study Sheds Light on Painkillers' Heart Risk

...nd to increase the risk of heart attack and stroke. Three cox-2 inhibitor NSAIDs have been marketed in the United States. Two of them -- Bextra and vioxx -- were withdrawn from the market earlier this decade because of their association with an increased risk of heart attack and stroke. A third cox-2, C...

Vioxx's Heart Risk Lingered Long After Use Ended

..., Oct. 13 (HealthDay News) -- When the pain killer vioxx was pulled from the market in 2004 -- over concern...clude cox-2 inhibitor drugs such as the now-banned vioxx and Bextra, as well as the remaining cox-2 on the ...in the international APPROVe trial, which compared vioxx to placebo over 3 years in an attempt to see wheth...

Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation

...sson engaged in a scheme to fraudulently inflate the price of more than 400 prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor, vioxx and more. On March 18, 2008, Judge Patti Saris for a second time rejected McKesson's motions to dismiss the case, citing the strength of the evidenc...

New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers

...its against Pfizer, Inc., the manufacturer of the hugely popular Chantix smoking cessation drug; and for its role in the ground-breaking $4.85 billion vioxx settlement against Merck & Co. "It's been a very busy summer for the firm which, in a recent span of just http://thesandersfirm.com/news...

Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.'s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan

... "Company") (NYSE: MRK ) to disclose material facts relating to Vytorin cannot be pursued as part of the ERISA action dealing with issues relating to vioxx and should be pursued in a separate case. To date, lawsuits have been filed that allege that the investments in the Merck Common Stock Fund within the...

Merck Wins Appeal of First VIOXX(R) Case to go to Trial

...y and rendered a judgment in favor of Merck in the vioxx product liability case Ernst v. Merck. It was the first vioxx case to go to trial after the Company voluntarily ...raud awards in the 2006 verdict in a two-plaintiff vioxx trial involving Thomas Cona and John McDarby. "W...

FDA Panel Considers Toll-Free Number for TV Drug Ads

...ide effects," she said. "That's when the real test happens." For example, the potentially deadly cardiovascular side effects of the arthritis drug vioxx weren't discovered until the drug had been on the market for several years. The FDA does have a method for consumers to report adverse side effect...

Celebrex Plus Lipitor Could Fight Prostate Cancer

...ly would be very safe," Ennis said. (Celebrex, a cox-2 inhibitor, is the only drug in this class still on the market in the United States; two others, vioxx and Bextra, were withdrawn because of safety issues). In the study, the investigators first cultured prostate tumors in mice, then added in either ...

Peter Burg Appointed as Co-Chair of the Plaintiffs' Steering Committee and the Executive Committee for the Gadolinium-Based Contrast Agents Product Liability Multi-District Litigation

...ieved in the mass torts arena as a result of our excellent work in previous MDL proceedings, specifically the Bextra-Celebrex, Zyprexa, Ortho Evra and vioxx MDLs." A number of firm attorneys sit on Plaintiffs' Steering Committees in pharmaceutical litigation as well as State Liaison Committees, Discovery C...

Drugs Approved Under Deadline More Likely to Run Into Trouble Later

... before the six-month deadline, then given a black-box warning, withdrawn from the market, and eventually reintroduced. The infamous arthritis drug vioxx was also a priority drug, approved within six months and later withdrawn because of cardiac side effects, to much hoopla. "In doing a lot of inter...

Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation

...sson engaged in a scheme to fraudulently inflate the price of more than 400 prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor, vioxx and more. "We have been fighting this battle on behalf of smaller groups for years," said Hagens Berman managing partner and lead attorney Steve Ber...

Stem Cell Technology Offers Promise of Huge Savings for Drug Developers

... in humans. Some unsafe products advance through testing and approval, only to be pulled from the market later at a huge expense, as was the case with vioxx and Bextra. Though stem cell-based drug development technologies are in an early stage of development, and will most likely not become available bef...

Special Masters Appointed in Program to Resolve U.S. VIOXX(R) Product Liability Lawsuits

...strator permitted under the resolution program for vioxx product liability litigation in the United States,...ndations from Judge Carol Higbee, who oversees the vioxx cases in New Jersey state court, and Judge Victoria Chaney, who oversees the vioxx cases in California state court. "The Special ...

In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market

...arch 7 /PRNewswire/ -- The rheumatoid arthritis (RA) treatment market, held back somewhat in recent years by generic competition and the withdrawal of vioxx and Bextra, is rebounding due to the performance of biologic treatments. The market for prescription drugs to treat RA topped $12 billion in 2006 and ...

Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer

...pen PGE2 production and aromatase activity. COX-2 inhibitors (which include vioxx and Celebrex) may do the same. However, these drugs also suppress a prostanoid that helps protect the heart, and in 2004 vioxx was withdrawn from the market due to an excess of cardiovascular events not...

Popular arthritis drug may disrupt heart rhythm, UB research finds

...nels, the study showed. The adverse effects of drugs like Celebrex and vioxx based on their selective inhibition of COX-2 currently are a topic of inten... School of Medicine and Biomedical Sciences and senior author on the study. vioxx was withdrawn from the market in September 2004. We now have shown an i...

Drug Safety, Tainted Food Among Year's Top Health Stories

... ("good") cholesterol. The drug's maker, Pfizer Inc., had already pulled the plug on its torcetrapib trial in 2006, following similar results. The vioxx saga, which began when the prescription painkiller was pulled from the market due to heart risks in 2004, may have reached a financial close this year...

How to Survive an Unexpected Trip to the Hospital During Christmas and New Years

...s is better than simply telling someone what you take, because medication names sometimes sound alike and are easily confused: Flomax could be Volmax, vioxx could by Zyvox, and Celebrex has been confused with Cerebyx and Celexa. 3. If you need X-rays or other diagnostic tests late at night or on a holi...

FDA Report Says Nation's Health at Risk

... Board on Monday. In recent years, numerous food recalls and the withdrawal from the market of popular medications -- the removal of the painkiller vioxx in 2004 was one of the most high-profile examples -- have eroded public confidence in the FDA. A recent survey found that 47 percent of Americans rate...
Other Tags
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
(Date:7/10/2014)... Mass. , June 30, 2014  Aware, Inc. ... biometrics software and services, previously announced on June 26, ... special cash dividend of $1.75 per share, or approximately ... date of July 10, 2014 and a payment date ... by NASDAQ that it had set an ex-dividend date ...
(Date:7/10/2014)... N.Y. , July 2, 2014 It ... (ABD) to announce the appointment of the world-renowned Thoracic ... Board of Directors. Dr. Ginsburg, with over ... facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical ... Pacemaker since the late 1980,s and is considered an ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
(Date:7/11/2014)... 11, 2014 Alliance for Cancer ... non-profit dedicated exclusively to cell and gene therapies ... has joined the organization as Senior Development Officer. ... deep experience securing gifts and addressing influential donors. ... Giving Director for NewYork Presbyterian Hospital/Columbia University Medical ...
(Date:7/11/2014)... 2014 Global enterprises today are shifting ... day-to-day management activities. Managed services offer these global enterprises ... economic slowdown resulted into rising operational costs to companies. ... considered to be the global market driver for expanding ... global managed services market is estimated to grow from ...
(Date:7/11/2014)... July 11, 2014 Presently, disposable medical ... healthcare equipment and supplies segment. During the past two ... steady growth (on an average 12.5% per year), primarily ... settings. Currently, the US is the largest market for ... share of 40%. The second position is held by ...
(Date:7/11/2014)... Researchers from The Miriam Hospital have found that ... significantly higher rates of smoking than those without ... less likely to attempt quitting than those without ... be sufficient for this population. The study and ... print in the American Journal of Public ...
(Date:7/11/2014)... has found that organic foods and crops have ... including more antioxidants and fewer, less frequent pesticide ... 343 peer-reviewed publications comparing the nutritional quality and ... fruits, vegetables, and grains. The study team applied ... and non-organic foods. , "Science marches on," ...
Breaking Medicine News(10 mins):Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3
Other Contents